Preliminary data from ongoing Phase 1/2 trials show BEAM-302 is well tolerated and achieves dose-dependent, durable ...

These results strengthen the scientific foundation for Lantern Pharma Inc. (NASDAQ:LTRN)’s FDA Rare Pediatric Disease ...

Estrella Immunopharma, Inc. (NASDAQ: ESLA) has announced a major milestone in its STARLIGHT-1 Phase I/II clinical trial, ...

Cytek Biosciences, Inc. (NASDAQ:CTKB) has announced the launch of its latest innovation, the Cytek Aurora Evo system, marking ...

Pfizer Inc. (NYSE: PFE) is navigating a period of strategic upheaval and legal scrutiny as it ends its clinical collaboration ...

Danaher Corporation (NYSE:DHR) and AstraZeneca PLC (NASDAQ:AZN) have announced a major partnership to accelerate the ...

On Thursday, Morgan Stanley lifted NVIDIA Corporation (NASDAQ: NVDA )’s stock price target to $170 from $160, while ...

Morgan Stanley lifted Salesforce, Inc. (NYSE:CRM)’s stock price target from $393 to $404, while maintaining an Overweight ...

Tariff drama has been lingering for quite some time now, and with uncertainty around policy implementation by the U.S.

Elbit Systems Ltd. (NASDAQ:ESLT)’s naval portfolio continues to evolve amid robust demand for real-time intelligence, ...